Schedule 13G ownership disclosure

FOAMIX PHARMACEUTICALS LTD

Security class unavailable · CUSIP: M46135105

Event date: 2016-09-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.5700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-16-008429
Form type
SC 13G
Filer
Foamix Pharmaceuticals Ltd.
CIK
CIK 1606645
Filed
Oct 11, 2016
Reporting period
Sep 28, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub